International Journal of Medical and Pharmaceutical Research
2022, Volume-3, Issue-2 doi: 10.5281/zenodo.7756734
Original Article
Mumps in Children: Clinical Characteristics Observed in a Tertiary Care Hospital in Bangladesh
 ,
 ,
 ,
Abstract
Background: Mumps is a contagious viral infection that primarily affects children and young adults. The disease is characterized by swelling of the salivary glands, which causes pain and fever. Although the incidence of mumps has decreased in recent years due to vaccination, outbreaks continue to occur. Mumps can lead to serious complications, such as meningitis, encephalitis, and pancreatitis, particularly in unvaccinated individuals. Aim of the study: The aim of the study was to understand the epidemiology, clinical features, and management of mumps in children is crucial for preventing and managing outbreaks. Methods: This hospital-based prospective observational study was conducted at the Department of Pediatric High Dependency and isolation, Bangladesh Shishu Hospital & Institute, Dhaka, Bangladesh. This study enrolled and analyzed sixty patients from January 2019 to December 2021. Result: The majority of patients, 56.67%, were between 6-10 years old, 23.33% were between 1-5 years old, 13.33% were between 11-15 years old, and 6.67% were between 16-18 years old. The mean duration of illness was 9.0±2 days. Furthermore, 60% of patients experienced constitutional symptoms such as headache, myalgia, or fatigue. Cough and dysphagia were observed in 83.33% and 47% of the patients, respectively. Conclusion: In conclusion, preventing mumps in children is crucial to reducing the disease burden in Bangladesh. Vaccination is the most effective way to prevent mumps, and the vaccine is available in the country's national immunization program. However, vaccine coverage must be improved to ensure that all children receive the vaccine.
Recommended Articles
Loading Image...
Volume-3, Issue-2
Citations
2621 Views
360 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved